Latest news
ALX Oncology Holdings Inc 2Q 2026: Net loss $17.97M, Diluted EPS $(0.13) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTALX Oncology Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:42:30 GMTALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 12:53:24 GMTALX Oncology Reports Q2 2026 Net Loss of $18 Million - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 12:16:00 GMTALX Oncology Holdings (ALXO) Slips Marginally as Investors Weigh Clinical Pipeline Against Cash Position - Market Cap Weight - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 02:37:28 GMTALX Oncology Holdings Inc (ALXO) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTALXO|ALX Oncology Holdings Inc|Price:1.985|Chg%:+0.055 - TradingKeyTradingKey · Thu, 30 Jul 2026 07:00:00 GMTALX Oncology Holdings Inc (ALXO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKeyTradingKey · Tue, 28 Jul 2026 07:25:32 GMT